Search research articles
Contact Us
Filters
Showing results (371-380 of 393) with videos related to
Page
of 40
Sort By:
Current Microbiology
|
February 21, 2019
Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases
José J Degrossi, Cindy Merino, Adela M Isasmendi, et al.
Antimicrobial Agents and Chemotherapy
|
October 18, 2023
Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in <i>Pseudomonas</i>-derived cephalosporinase
Andrew R Mack, Vijay Kumar, Magdalena A Taracila, et al.
Antimicrobial Agents and Chemotherapy
|
August 22, 2012
Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3
Krisztina M Papp-Wallace, Baui Senkfor, Julian Gatta, et al.
Journal of Medicinal Chemistry
|
December 21, 2012
Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) β-lactamase
Marisa L Winkler, Elizabeth A Rodkey, Magdalena A Taracila, et al.
Biochemical Pharmacology
|
December 14, 2011
Inactivation of a class A and a class C β-lactamase by 6β-(hydroxymethyl)penicillanic acid sulfone
Krisztina M Papp-Wallace, Christopher R Bethel, Thomas D Gootz, et al.
Antimicrobial Agents and Chemotherapy
|
January 28, 2025
Restoring cefepime activity against multidrug-resistant KPC-producing <i>Klebsiella pneumoniae</i> by combination with boronic acid inhibitors, MB076 and S02030
Laura J Rojas, Travis B Nielsen, Paul Pantapalangkoor, et al.
Scientific Reports
|
November 23, 2019
Human pleural fluid triggers global changes in the transcriptional landscape of Acinetobacter baumannii as an adaptive response to stress
Jasmine Martinez, Jennifer S Fernandez, Christine Liu, et al.
Biochemistry
|
April 28, 2015
Exploring the Role of Residue 228 in Substrate and Inhibitor Recognition by VIM Metallo-β-lactamases
Maria F Mojica, S Graciela Mahler, Christopher R Bethel, et al.
Antimicrobial Agents and Chemotherapy
|
March 21, 2022
Different Conformations Revealed by NMR Underlie Resistance to Ceftazidime/Avibactam and Susceptibility to Meropenem and Imipenem among D179Y Variants of KPC β-Lactamase
Magdalena A Taracila, Christopher R Bethel, Andrea M Hujer, et al.
The Journal of Infectious Diseases
|
May 18, 2019
Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa
Krisztina M Papp-Wallace, Elise T Zeiser, Scott A Becka, et al.
Page
of 40
Search research articles
Search
Showing results (371-380 of 393) with videos related to
Sort By:
Page
of 40
Current Microbiology
|
February 21, 2019
Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases
José J Degrossi, Cindy Merino, Adela M Isasmendi, et al.
Antimicrobial Agents and Chemotherapy
|
October 18, 2023
Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in <i>Pseudomonas</i>-derived cephalosporinase
Andrew R Mack, Vijay Kumar, Magdalena A Taracila, et al.
Antimicrobial Agents and Chemotherapy
|
August 22, 2012
Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3
Krisztina M Papp-Wallace, Baui Senkfor, Julian Gatta, et al.
Journal of Medicinal Chemistry
|
December 21, 2012
Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) β-lactamase
Marisa L Winkler, Elizabeth A Rodkey, Magdalena A Taracila, et al.
Biochemical Pharmacology
|
December 14, 2011
Inactivation of a class A and a class C β-lactamase by 6β-(hydroxymethyl)penicillanic acid sulfone
Krisztina M Papp-Wallace, Christopher R Bethel, Thomas D Gootz, et al.
Antimicrobial Agents and Chemotherapy
|
January 28, 2025
Restoring cefepime activity against multidrug-resistant KPC-producing <i>Klebsiella pneumoniae</i> by combination with boronic acid inhibitors, MB076 and S02030
Laura J Rojas, Travis B Nielsen, Paul Pantapalangkoor, et al.
Scientific Reports
|
November 23, 2019
Human pleural fluid triggers global changes in the transcriptional landscape of Acinetobacter baumannii as an adaptive response to stress
Jasmine Martinez, Jennifer S Fernandez, Christine Liu, et al.
Biochemistry
|
April 28, 2015
Exploring the Role of Residue 228 in Substrate and Inhibitor Recognition by VIM Metallo-β-lactamases
Maria F Mojica, S Graciela Mahler, Christopher R Bethel, et al.
Antimicrobial Agents and Chemotherapy
|
March 21, 2022
Different Conformations Revealed by NMR Underlie Resistance to Ceftazidime/Avibactam and Susceptibility to Meropenem and Imipenem among D179Y Variants of KPC β-Lactamase
Magdalena A Taracila, Christopher R Bethel, Andrea M Hujer, et al.
The Journal of Infectious Diseases
|
May 18, 2019
Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa
Krisztina M Papp-Wallace, Elise T Zeiser, Scott A Becka, et al.
Page
of 40